Goodwin announced today the release of its 2016 BPCIA Litigation Update and Thinking of Investing In a Biosimilars Product? The 2016 BPCIA Litigation Update recaps a busy year in the legal world of biosimilars, offering background, legal analysis and the status of the year’s most pivotal cases. Thinking of Investing In a Biosimilars Product? outlines key considerations for investors interested in the space. For more information about both publications and to download your copies, please click here.
The post Goodwin Publishes Biosimilars Patent Litigation Update, Biosimilars Investment Guidelines appeared first on Big Molecule Watch.